APUS - Bathi sadurunge bunga, pajak, lan amortisasi Apimeds Pharmaceuticals US

The GURU.Markets service features a linear chart of actual operating profit, where the value of 0.00 characterizes this level. Apimeds Pharmaceuticals (APUS) focuses on creating Apitox, a natural remedy for arthritis. However, international patent protection and logistical complexities are hindering expansion. FDA approval and the completion of final clinical trial stages will serve as the primary growth drivers.

APUS Apimeds Pharmaceuticals: Bathi sadurunge mbayar bunga, pajak, lan amortisasi ing interval 23.11.2025 - 10.11.2026

Ringkesan rincian data analitis Apimeds Pharmaceuticals US (APUS)

- rega saham lan prakiraan rega para ahli:

Kurs saham Apimeds Pharmaceuticals, Inc.|APUS - Prakiraan konsensus analis

- statistik kapitalisasi pasar:

Nilai pasar Apimeds Pharmaceuticals|APUS - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- data kapitalisasi buku:

Nilai Buku saben Saham Apimeds Pharmaceuticals|APUS - Nilai Buku Perusahaan|Nilai Pasar marang Nilai Buku apimedsus.com|APUS - Aset Agregat Perusahaan

- indikator total utang lan likuiditas perusahaan:

Utang marang Modal Apimeds Pharmaceuticals|APUS - Utang jangka dawa marang ekuitas|Utang jangka cendhak marang ekuitas Apimeds Pharmaceuticals, Inc.|APUS - Utang perusahaan|Utang-utang marang nilai buku Apimeds Pharmaceuticals|APUS - Utang jangka dawa perusahaan|Tanggungan jangka cendhak Apimeds Pharmaceuticals|Likuiditas darurat apimedsus.com

- data bathi bisnis lan rasio investasi:

APUS - Bathi resik|Proyeksi bathi mangsa ngarep Apimeds Pharmaceuticals|APUS - Rasio rega marang bathi|Rasio rega marang bathi sing dikarepake Apimeds Pharmaceuticals, Inc.|APUS - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Apimeds Pharmaceuticals|APUS - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone 12 wulan pungkasan Apimeds Pharmaceuticals|APUS - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan apimedsus.com|APUS - Wutah bathi ing taun lumaku|Proyeksi kacepetan wutah bathi saben saham kanggo taun ngarep Apimeds Pharmaceuticals

Analisis kabeh metrik perusahaan:Apimeds Pharmaceuticals

Produk asil prodhuksi Apimeds Pharmaceuticals, Inc.

This indicator is calculated as the daily difference between operating income and expenses, allowing investors to identify abnormal profit spikes that often signal the exhaustion of growth drivers. By analyzing the operating profit of Apimeds Pharmaceuticals (APUS), one can assess the monetization efficiency of unique bee venom peptides and the high pricing power of Apimeds Pharmaceuticals (APUS) within the inelastic demand segment for neurological disease treatment.

Karo sapa Apimeds Pharmaceuticals saingan